​

Gossamer Bio Ownership | Who Owns Gossamer Bio?

OverviewForecastRevenueFinancialsChart

Gossamer Bio Ownership Summary

Gossamer Bio is owned by 77.26% institutional investors, 2.95% insiders, and 19.79% retail investors. Nea management company is the largest institutional shareholder, holding 8.02% of GOSS shares. Fidelity Select Biotechnology is the top mutual fund, with 3.50% of its assets in Gossamer Bio shares.

GOSS Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockGossamer Bio77.26%2.95%19.79%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Nea management company18.09M8.02%$16.30M
Vanguard group11.76M5.21%$10.59M
Octagon capital advisors lp9.19M4.07%$8.28M
Arch venture management8.06M3.57%$7.26M
Fmr7.93M3.51%$7.14M
Palo alto investors lp6.28M2.78%$5.66M
Samsara biocapital6.13M2.72%$5.52M
683 capital management5.75M2.55%$5.18M
Millennium management5.60M2.48%$5.04M
Silverarc capital management5.50M2.44%$4.95M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Arch venture management8.06M2.73%$7.26M
Octagon capital advisors lp9.19M1.30%$8.28M
Nea management company18.09M1.23%$16.30M
Silverarc capital management5.50M1.17%$4.95M
Samsara biocapital6.13M1.16%$5.52M
Exome asset management1.13M0.90%$1.02M
Opaleye management3.91M0.80%$3.52M
Palo alto investors lp6.28M0.66%$5.66M
683 capital management5.75M0.39%$5.18M
Monaco asset management sam2.73M0.39%$2.46M

Top Buyers

HolderShares% AssetsChange
Alyeska investment group5.49M0.03%5.49M
Price t rowe associates inc /md/5.49M0.00%2.60M
683 capital management5.75M0.39%2.50M
Nea management company18.09M1.23%2.26M
Monaco asset management sam2.73M0.39%2.17M

Top Sellers

HolderShares% AssetsChange
Ecor1 capital---9.20M
Farallon capital management---6.13M
Madison avenue partners, lp---4.14M
Morgan stanley194.66K--4.14M
Monashee investment management859.85K0.10%-2.60M

New Positions

HolderShares% AssetsChangeValue
Exome asset management1.13M0.90%1.13M$1.02M
Barclays769.63K0.00%769.63K$693.00K
Algert global83.54K0.00%83.54K$75.00K
Choreo48.11K0.00%48.11K$45.59K
Nomura40.00K0.00%40.00K$36.04K

Sold Out

HolderChange
Zurcher kantonalbank (zurich cantonalbank)-4.00
Global retirement partners-300.00
Northwestern mutual wealth management-500.00
Cape investment advisory-7.00K
Macquarie group-9.27K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20241077.00%174,874,925-4.36%771.18%447.32%27-10.00%
Jun 30, 2024100-11.50%182,850,856-7.56%811.05%41-21.15%30-3.23%
Mar 31, 202411310.78%197,807,122-5.44%871.02%52-5.45%3147.62%
Dec 31, 20231024.08%209,181,5402.23%920.82%55-12.70%2116.67%
Sep 30, 202398-4.85%204,620,341229.97%10610.26%63110.00%18-57.14%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Select Biotechnology7.91M3.50%-
Vanguard Total Stock Mkt Idx Inv7.84M3.46%-
Federated Hermes Kaufmann Small Cap Grow3.83M1.69%-
Federated Hermes Kaufmann Small Cap A3.83M1.69%-
Vanguard Institutional Extnd Mkt Idx Tr2.88M1.27%-
Fidelity Extended Market Index1.10M0.49%239.67K
Schwab US Small-Cap ETF™903.99K0.40%-
Vanguard Health Care ETF642.15K0.28%-1.67K
Victory Science & Technology579.40K0.26%-4.21K
Bridgeway Ultra-Small Company Market535.00K0.24%-

Recent Insider Transactions

DateNameRoleActivityValue
Jun 24, 2024Aranda Richard Chief Medical OfficerSell$1.26K
Jun 21, 2024Hasnain Faheem President & CEOBuy$250.28K
Jun 18, 2024Giraudo Bryan COO/CFOBuy$59.11K
Jun 17, 2024Smith Robert Paul JR Chief Commercial OfficerBuy$15.05K
Mar 27, 2024Christian Waage EVP, Tech Ops and AdminSell$7.43K

Insider Transactions Trends

DateBuySell
2024 Q231
2024 Q1-5
2023 Q42-
2023 Q3--
2023 Q211

GOSS Ownership FAQ

Who Owns Gossamer Bio?

Gossamer Bio shareholders are primarily institutional investors at 77.26%, followed by 2.95% insiders and 19.79% retail investors. The average institutional ownership in Gossamer Bio's industry, Biotech Stocks , is 47.04%, which Gossamer Bio exceeds.

Who owns the most shares of Gossamer Bio?

Gossamer Bio’s largest shareholders are Nea management company (18.09M shares, 8.02%), Vanguard group (11.76M shares, 5.21%), and Octagon capital advisors lp (9.19M shares, 4.07%). Together, they hold 17.30% of Gossamer Bio’s total shares outstanding.

Does Blackrock own Gossamer Bio?

BlackRock is not among the top 10 institutional shareholders of Gossamer Bio.

Who is Gossamer Bio’s biggest shareholder by percentage of total assets invested?

Arch venture management is Gossamer Bio’s biggest shareholder by percentage of total assets invested, with 2.73% of its assets in 8.06M Gossamer Bio shares, valued at 7.26M$.

Who is the top mutual fund holder of Gossamer Bio shares?

Fidelity Select Biotechnology is the top mutual fund holder of Gossamer Bio shares, with 3.50% of its total shares outstanding invested in 7.91M Gossamer Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools